Liquid biopsy advances could yield new tool for detecting lung cancer mutations

In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...
National Institute for Health and Care Excellence

EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer

Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer: equality impact assessment - guidance Epidermal ...
Targeted Oncology

Examining Biomarker Testing in Early-stage NSCLC

Experts discuss the underutilization of biomarker testing in metastatic lung cancer, emphasizing the need for improved ...
Medscape

Tests in the Works to Determine Who Will Benefit From EGFR Inhibitors

May 14, 2008 — The blocking of epidermal growth-factor receptors (EGFR) to treat non-small-cell lung cancer is becoming increasingly common, but there is considerable debate about when to initiate ...
Oregonian

Dear Doctor: How does blood test eGFR number reflect kidney function, and what range is ‘normal’?

DEAR DR. ROACH: I am a 73-year-old female. A recent blood test returned an eGFR (estimated glomerular filtration rate) of 59. My physician’s nurse told me that the test was normal. When I asked her ...
MadameNoire

Black Kidney Patients Delayed Care Due To Race-Based Test

A race-specific algorithm designed to assess kidney function for individuals awaiting transplants jeopardized critical treatment for some Black Americans. An exclusive report by the Associated Press ...
National Institute for Health and Care Excellence

EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer

The diagnostics advisory committee reviewed the evidence available on the clinical and cost effectiveness of epidermal growth factor receptor tyrosine kinase (EGFR‑TK) mutation testing to inform first ...